Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds

Polypharmacology by Design: A Medicinal Chemist's Perspective on  Multitargeting Compounds

Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds

Polypharmacology by Design: A Medicinal Chemist's Perspective on  Multitargeting Compounds

From combinations to multitarget‐directed ligands: A continuum in Alzheimer's disease polypharmacology - Albertini - 2021 - Medicinal Research Reviews - Wiley Online Library

Polypharmacology by Design: A Medicinal Chemist's Perspective on  Multitargeting Compounds

IJMS, Free Full-Text

Polypharmacology by Design: A Medicinal Chemist's Perspective on  Multitargeting Compounds

Molecules, Free Full-Text

Polypharmacology by Design: A Medicinal Chemist's Perspective on  Multitargeting Compounds

Systems Pharmacology: When multi-targeting is advantageous - Drug Discovery World (DDW)

Polypharmacology by Design: A Medicinal Chemist's Perspective on  Multitargeting Compounds

Polypharmacology: promises and new drugs in 2022

Polypharmacology by Design: A Medicinal Chemist's Perspective on  Multitargeting Compounds

Drug Design: Most Up-to-Date Encyclopedia, News & Reviews

Polypharmacology by Design: A Medicinal Chemist's Perspective on  Multitargeting Compounds

Polypharmacology: promises and new drugs in 2022

Polypharmacology by Design: A Medicinal Chemist's Perspective on  Multitargeting Compounds

Phenotypic drug discovery: recent successes, lessons learned and new directions. - Abstract - Europe PMC

Polypharmacology by Design: A Medicinal Chemist's Perspective on  Multitargeting Compounds

Evolution of kinase polypharmacology across HSP90 drug discovery

Polypharmacology by Design: A Medicinal Chemist's Perspective on  Multitargeting Compounds

In silico methods to address polypharmacology: current status, applications and future perspectives.

Polypharmacology by Design: A Medicinal Chemist's Perspective on  Multitargeting Compounds

Evolution of kinase polypharmacology across HSP90 drug discovery

Polypharmacology by Design: A Medicinal Chemist's Perspective on  Multitargeting Compounds

Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacology - Journal of Biological Chemistry

Polypharmacology by Design: A Medicinal Chemist's Perspective on  Multitargeting Compounds

Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds

Polypharmacology by Design: A Medicinal Chemist's Perspective on  Multitargeting Compounds

Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds